HP1142 是FLT3受体酪氨酸激酶 (FLT3/ITD 突变) 的有效和具有选择性抑制剂。HP1142 是一种基于苯并咪唑支架的化合物。HP1142 具有研究FLT3/ITD 白血病的潜力。

HP1142 is a potent and selective inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1142 is a benzoimidazole scaffold-based compound. HP1142 has the potential for the research of FLT3/ITD leukemia [1].

381173-58-6

C22H21N3O2

359.42

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years